U.S. flag

An official website of the United States government

NM_000153.4(GALC):c.1589T>C (p.Leu530Pro) AND Galactosylceramide beta-galactosidase deficiency

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 22, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002250959.1

Allele description [Variation Report for NM_000153.4(GALC):c.1589T>C (p.Leu530Pro)]

NM_000153.4(GALC):c.1589T>C (p.Leu530Pro)

Gene:
GALC:galactosylceramidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q31.3
Genomic location:
Preferred name:
NM_000153.4(GALC):c.1589T>C (p.Leu530Pro)
HGVS:
  • NC_000014.9:g.87945634A>G
  • NG_011853.3:g.52930T>C
  • NM_000153.4:c.1589T>CMANE SELECT
  • NM_001201401.2:c.1520T>C
  • NM_001201402.2:c.1511T>C
  • NP_000144.2:p.Leu530Pro
  • NP_001188330.1:p.Leu507Pro
  • NP_001188331.1:p.Leu504Pro
  • NC_000014.8:g.88411978A>G
Protein change:
L504P
Links:
dbSNP: rs2139951392
NCBI 1000 Genomes Browser:
rs2139951392
Molecular consequence:
  • NM_000153.4:c.1589T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001201401.2:c.1520T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001201402.2:c.1511T>C - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Galactosylceramide beta-galactosidase deficiency
Synonyms:
Krabbe leukodystrophy; Globoid cell leukoencephalopathy; Galactocerebrosidase deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009499; MedGen: C0023521; Orphanet: 487; OMIM: 245200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV0025212173billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(May 22, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot provided1not providedclinical testing

Citations

PubMed

Large-scale study of clinical and biochemical characteristics of Chinese patients diagnosed with Krabbe disease.

Zhao S, Zhan X, Wang Y, Ye J, Han L, Qiu W, Gao X, Gu X, Zhang H.

Clin Genet. 2018 Feb;93(2):248-254. doi: 10.1111/cge.13071. Epub 2017 Oct 17.

PubMed [citation]
PMID:
28598007

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From 3billion, SCV002521217.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (2)

Description

The variant is not observed in the gnomAD v2.1.1 dataset. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.88; 3Cnet: 0.57). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with GALC related disorder (PMID: 28598007). However, the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as uncertain significanceaccording to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Dec 24, 2023